title: Bleb infections: clinically different courses of "blebitis" and endophthalmitis.
abstract: OBJECTIVE
  To assess the differences in history, clinical course, and response between five cases of blebitis and three cases of endophthalmitis following mitomycin trabeculectomy.
  
  
  METHODS
  The authors conducted a retrospective review of eight consecutive cases of bleb-related infection following successful mitomycin trabeculectomy.
  
  
  RESULTS
  All patients with blebitis responded to treatment with return of visual acuity and intraocular pressure to preinfection levels. In the three cases of endophthalmitis, one patient underwent enucleation, one had a final visual acuity of counting fingers, and the third had a visual acuity of 20/60.
  
  
  CONCLUSIONS
  Blebitis, a limited form of bleb-related infection with thin, cystic, leaky blebs, responds to intensive topical antibiotic treatment, returning visual acuity and IOP to preinfection levels. Bleb-related endophthalmitis causes a more virulent form of bleb-related infection that involves thin- or thick-walled blebs, with or without leakage, and poor visual prognosis despite immediate intensive topical, systemic, and intravitreal antibiotic administration combined with core vitrectomy.
authors.affiliation: Department of Ophthalmology, Harverd Medical School, Baston, MA, USA.
authors.forename: R S
authors.initials: RS
authors.lastname: Ayyala
authors.forename: A R
authors.initials: AR
authors.lastname: Bellows
authors.forename: J V
authors.initials: JV
authors.lastname: Thomas
authors.forename: B T
authors.initials: BT
authors.lastname: Hutchinson
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D001419:Bacteria / Q000302:isolation & purification; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003228:Conjunctiva / Q000382:microbiology; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D009877:Endophthalmitis / Q000382:microbiology* / Q000473:pathology / Q000628:therapy; D015818:Eye Infections, Bacterial / Q000209:etiology / Q000473:pathology / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D005901:Glaucoma / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D008937:Mitomycins / Q000008:administration & dosage; D009883:Ophthalmic Solutions; D011183:Postoperative Complications / Q000209:etiology / Q000473:pathology / Q000628:therapy; D012086:Reoperation; D012189:Retrospective Studies; D014130:Trabeculectomy / Q000009:adverse effects*; D014821:Vitrectomy; D014822:Vitreous Body / Q000382:microbiology / Q000601:surgery
chemical_list: D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D008937:Mitomycins; D009883:Ophthalmic Solutions